D03.30
Melanoma in situ of unspecified part of face
Clinical Classification Guidelines
Medical Intelligence & Overview
Melanoma in situ of the face is an early, localized form of skin cancer where abnormal pigment cells, called melanocytes, are confined to the outermost layer of the skin. It is considered the earliest stage of melanoma, offering a good chance for successful treatment when diagnosed promptly. The face is a common site due to sun exposure, and recognizing this condition is important for skin health and cancer prevention.
Causes & Symptoms
Clinical Causes: Chronic and excessive exposure to ultraviolet (UV) rays from the sun or tanning beds History of sunburns, especially during childhood Fair skin that easily burns or develops freckles Presence of numerous moles or atypical moles Family history of melanoma or other skin cancers Weakened immune system
Key Symptoms: Appearance of a new or changing mole on the face A flat, pigmented, irregularly shaped lesion that may be different in color Lesions that have uneven borders or multiple colors (brown, black, tan, or even pink) Itching, tenderness, or bleeding in the affected area (less common in melanoma in situ) Lesions that persist or grow over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough skin examination by a healthcare professional. If a suspicious lesion is identified, a skin biopsy is performed to confirm whether melanoma cells are present and whether the melanoma is confined to the surface layer. Additional imaging or tests might be conducted to rule out spread or involvement of other areas, but in situ melanomas are localized.
Treatment Protocols: Treatment generally involves surgical removal of the lesion with clear margins to ensure complete excision. In some cases, Mohs micrographic surgery may be used for precision. Regular follow-up and skin checks are recommended to monitor for new or recurring lesions. Additional therapies are rarely needed at this stage unless there is evidence of spread or progression.
Clinical Advice & FAQs
Billing Guidance
Is D03.30 a billable ICD-10 code?
Yes, D03.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D03.30?
Clinical documentation must specify the nature of Melanoma in situ of unspecified part of face and any associated comorbidities for accurate reporting.
Cite this Clinical Reference